Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Proteostasis Therapeutics, Inc.

NASDAQ: PTITechnology / Application Software / India
4.70-0.05-1.05%Vol 189 5081Y Perf 94.19%
Dec 10th, 2018 15:21
BID4.70 ASK4.71
Open4.78 Previous Close4.75
Pre-Market- After-Trading4.75
 - -%  - -%
Target Price
14.00 
Analyst Rating
Strong Buy 1.25
Potencial %
199.79 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
100/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
100/100/100 
Growth Ranking
★+     40.96
Insiders Shares Cnt. % 3/6/12M
100/100/100 
Income Ranking
 —    -
Market Cap (mil)172 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
34.49 
Earnings Date
13th Nov 2018

Today's Price Range

4.614.94

 

52wk Range

1.7110.38

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
-33.94%
3 Months
91.53%
6 Months
60.47%
1 Year
94.19%
3 Years
-
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
PTI4.70-0.0500-1.05
AAPL168.710.22000.13
GOOG1 039.062.48000.24
MSFT106.962.14002.04
XOM76.10-1.5400-1.98
WFC48.79-1.4700-2.92
JNJ144.85-0.5800-0.40
FB142.034.61003.35
GE6.88-0.1300-1.85
JPM101.10-2.1900-2.12
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
4.00
Current Ratio
4.20
Long Term Debt to Total Capital
0.26
Total Debt to Equity
0.37
Interest Coverage
-
Leverage Ratio 1.40
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-1 326.60
EBITDA Margin
-1 311.80
Pre-tax Profit Margin
-764.30
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
6.62
PS Ratios
57.73
Price to Cash Flow
-
Price to Free Cash Flow
-5.00
Cash Flow Per Share
-1.54
Price to Tangible Book
6.62
Book Value per Share
0.77
Enterprise Value (in ths.)
225 697
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
141.11
ROE last 12 Months
-151.90
Return on Assets (5Y Avg)
-51.37
ROA last 12 Months
-94.08
Return on Capital (5Y Avg)
-
ROC last 12 Months
-111.10
Return on invested Capital Q
-29.88
Return on invested Capital Y
-80.00
Assets Turnover
0.10
Receivables Turnover
11.60
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
4 462
Revenue per Share
0.09
Revenue Growth 3 Years
0.50
Revenue Growth 5 Years
-
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-0.46-0.50-8.70
Q02 2018-0.41-0.43-4.88
Q01 2018-0.51-0.3237.25
Q04 2017-0.65-0.5121.54
Q03 2017-0.63-0.5611.11
Q02 2017-0.61-0.68-11.48
Q01 2017-0.58-0.60-3.45
Q04 2016-0.51-0.3825.49
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.468.00Positive
12/2018 FY-1.848.46Positive
3/2019 QR-0.503.85Positive
12/2019 FY-2.100.47Positive
Next Report Date-
Estimated EPS Next Report-0.46
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume189 508
Shares Outstanding (in ths.)36 700
Trades Count978
Dollar Volume806 490
Avg. Volume1 543 908
Avg. Weekly Volume302 167
Avg. Monthly Volume593 337
Avg. Quarterly Volume2 724 388

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

70%30%

Bearish Bullish

65%35%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (75.00 %)
3 (75.00 %)
2 (66.67 %)
Moderate Buy
1 (25.00 %)
1 (25.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
1 (33.33 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.25
Strong Buy
1.25
Moderate Buy
1.67

There are no comments yet.

News